Page last updated: 2024-10-15

dinitrochlorobenzene and Wiskott-Aldrich Syndrome

dinitrochlorobenzene has been researched along with Wiskott-Aldrich Syndrome in 2 studies

Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.

Wiskott-Aldrich Syndrome: A rare, X-linked immunodeficiency syndrome characterized by ECZEMA; LYMPHOPENIA; and, recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballow, M1
Dupont, B1
Hansen, JA1
Good, RA1
Griscelli, C1

Other Studies

2 other studies available for dinitrochlorobenzene and Wiskott-Aldrich Syndrome

ArticleYear
Transfer factor therapy: evidence for nonspecificity.
    Birth defects original article series, 1975, Volume: 11, Issue:1

    Topics: Antibody Formation; Candida albicans; Chickenpox; Child; Child, Preschool; Dinitrochlorobenzene; Esc

1975
Transfer factor therapy in immunodeficiency.
    Birth defects original article series, 1975, Volume: 11, Issue:1

    Topics: Antibody Formation; Candidiasis; Cell Migration Inhibition; Dinitrochlorobenzene; Hypersensitivity,

1975